NICE vs SRAD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

NICE

32.3
AI Score
VS
SRAD Wins

SRAD

64.9
AI Score

Investment Advisor Scores

NICE

32score
Recommendation
AVOID NEW MONEY

SRAD

65score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric NICE SRAD Winner
Forward P/E 9.4429 30.303 NICE
PEG Ratio 0.7871 0 Tie
Revenue Growth 7.6% 18.9% SRAD
Earnings Growth -52.7% -39.9% SRAD
Tradestie Score 32.3/100 64.9/100 SRAD
Profit Margin 13.9% 1.2% NICE
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY BUY SRAD

Relative Price Performance (Last 90 Days)

NICE 1M: +6.6% · 3M: +17.2% SRAD 1M: -9.0% · 3M: -27.0%

Current Technical Phase

NICE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.8% over 20 days), RSI 58

RSI (14): 57.7 · Price: $113.90

SRAD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.9%), weak momentum, RSI 40

RSI (14): 39.9 · Price: $11.76

Fundamentals Snapshot

Metric NICE SRAD
Market Cap — —
Forward P/E 9.0 30.2
Trailing P/E 16.2 197.7
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.7% 0.3%
Operating Margin 0.1% 0.1%
EPS 7.20 0.06
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SRAD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.